Cresco Labs faced a class action lawsuit in Illinois after marketing products without the required FDA approval.
2 reports, 1 independent
Updated Jan 1
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cresco Labs faced a class action lawsuit in Illinois after marketing products without the required FDA approval.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- An Illinois company supplied a lethal cocktail to Georgia, following the FDA's approval of the original anesthetic drug.Sub-event
Cresco Labs marketed products without FDA approval, leading to a class action in Illinois.1 source
Keep exploring
The entities involved
- FDA
-
Cresco Labs
American cannabis company
-
Illinois
state of the United States of America
Related events
- FDA and state authorities are investigating product manufacturers in Utah.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- The Charlotte Lozier Institute found that the FDA lacked sufficient evidence in its review process.
- FDA approval boosts the Korean drug industry, driving market attention for companies like SamChunDang Pharm.
- Litigation regarding FDA approval process.